Rethinking epilepsy care with therapeutic drug monitoring
A focused clinical approach to second-generation anti-seizure medications and laboratory diagnostics
A focused clinical approach to second-generation anti-seizure medications and laboratory diagnostics
Cleanroom microbiology expert, Cherwell, to become AnalytiChem UK Ltd from 1st September 2025
Understaffing in the lab threatens the collaboration doctors depend on
AliveDx has received IVDR-CE Mark for its multiplexed MosaiQ AiPlex Vasculitis (VAS) assay, designed to speed diagnosis of ANCA-associated vasculitides and Anti-GBM (Goodpasture’s) disease
46 companies and organizations were honored for supporting the association through advertising, sponsorships, and exhibits
First-of-its-kind study at ADLM 2025 lays the foundation for addressing public health threat
From concept to clinic, NExT gives researchers and developers access to Fujirebio’s unmatched expertise in neurological biomarker testing
New findings at ADLM 2025 could remedy this failure
Dr. Stanley F. Lo, DABCC, FADLM, has been elected to serve on the ADLM board of directors as president-elect starting in August 2025
The award recognises Gradientech’s impactful and innovative campaign to raise awareness about its QuickMIC ultra-rapid antibiotic susceptibility testing (AST) system
With a bold new identity and expanded capabilities, HiArc emerges as a next-generation engineering and manufacturing partner for the life science and diagnostics industry
ADLM 2025 studies highlight promising options for cervical and endometrial cancer
Forging a powerful partnership to accelerate global healthcare innovation and dominate the emerging AI-driven clinical decision support market
Key topics included the health effects of plastics, tackling medical misinformation, and advancing clinical care with AI
Discover how advances in dried blood spot testing are advancing biomarker analysis and sample collection
Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on neurodegenerative disease research
Multicenter study shows IntelliSep enables an increase in safe ED discharges, easing inpatient bed shortages without increasing 30-day return visits
The test operates using the company’s fully automated Lumipulse G1200 instrument system
Roche has been recognized as No. 1 in seven of nine award categories
Roche Diagnostics, Illumina, and Siemens Healthineers among those recognized
With global colorectal cancer rates on the rise, healthcare systems need smarter ways to screen patients. FIT testing is proving to be one of the most effective and efficient tools at their disposal.
The comprehensive portfolio advances laboratory processes through the ability to provide earlier and more efficient detection and diagnosis
New blood test unveiled developed using artificial intelligence could lead to improved patient outcomes
Lateral flow test development experts share troubleshooting tips and discuss how Merck’s Hi-Flow Plus membranes can streamline assay development
Offering early access to the new diagnostic paradigm, pilot partnerships with selected institutions engaged by year-end